Thinking Out Loud (Blog)
Press Release: Chugai Renews License to EpiVax’s ISPRI In Silico Toolkit for Immunogenicity Assessment
Announced today, Chugai Pharmaceutical Co., Ltd. ("Chugai"), a member of the Roche Group, will extend the company's licensed access to the Immunogenicity Screening and Protein Reengineering Interface (ISPRI) toolkit developed by EpiVax, Inc. ("EpiVax"). Chugai, one...
read more
Doing Well While Doing Good | August Blog
Tell us #WhatYouDidThisSummer! Summer is here! What are you doing this summer? Send us an email (click here) to let us know! We're working on "Improving Human Health Everywhere." I went to Bamako in July to check in on the GAIA Vaccine Foundation program there. GAIA...
read more
EpiVax Gives Back to the Bay!
Save The Bay's Fort Wetherill Cleanup Saturday, June 1st, 2019 10:00A.M-12:00P.M Fort Wetherill State Park Jamestown, Rhode Island On Saturday, June 1st, 2019, members of the EpiVax team volunteered at this month's shore cleanup with Save the Bay - Narragansett Bay....
read more
A Hobbit Birthday! | EpiVax’s June Events
A Hobbit Birthday We celebrated out 21st birthday in May! And so what's a hobbit birthday? It's when you give back instead of getting gifts. Read about EpiVax contributions to human health in our birthday Press Release. Want some birthday cake? Then come to our open...
read more
EpiVax Celebrates 21 Years of Improving Human Health Everywhere
EpiVax is celebrating its 21st birthday in Providence by renewing its commitment to improving human health everywhere and highlighting the work of two not-for-profit organizations that have been partners with EpiVax for nearly all of those 21 years. One of these...
read more
Soy Sauce and Gnarly Peptides | May Blog
Hope for HIV Found in Soy Sauce Flavor Enhancer Talk about re-purposing drugs - the "other" Japanese soy sauce manufacturer Yamasa (not Kikkoman) was developing oligonucleotides (yes!) for flavor enhancing properties. Re-screening their extensive library for potential...
read more